Analyst firms · Wedbush · ARVN
Wedbush ARVN price target and rating history
Arvinas Inc. (ARVN) · Health Care
Wedbush rates Arvinas Inc. (ARVN) Neutral with a $12 price target, as of its latest action on Mar 12, 2025. It has published 3 rating actions on ARVN since May 2022, including 1 upgrade and 2 downgrades.
- Current rating
- Neutral
- Price target
- $12
- Median target, all firms
- Too few
- Actions on ARVN
- 3
Wedbush price target on ARVN
Every Wedbush rating on ARVN
- Mar 12, 2025
- Oct 23, 2023
- May 9, 2022
How other firms rate ARVN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Equal Weight | Aug 4, 2026 | |
| Citigroup | Buy | $15 | Jan 6, 2026 |
Questions about Wedbush and ARVN
- What is Wedbush's price target for ARVN?
- Wedbush's latest stated price target for Arvinas Inc. (ARVN) is $12, from its action on Mar 12, 2025.
- What is Wedbush's rating on ARVN?
- Wedbush rates ARVN Neutral, a neutral rating, as of Mar 12, 2025.
- When did Wedbush last change its view on ARVN?
- On Mar 12, 2025, Wedbush downgrades to Neutral from Outperform, price target $57 to $12.
More ARVN rating histories
All Wedbush ratingsARVN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.